Ulrik Lassen
Copenhagen University Hospital
ORCID: 0000-0002-3865-4574Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 8 papers. Top paper: “Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial”.
Ulrik Lassen, Élena Elez, Antoîne Italiano, Giuseppe Curigliano, Milind Javle +14 more
Robert J. Kreitman, Zev A. Wainberg, Anas Gazzah, Ulrik Lassen, Alexander Stein +18 more
Daniel S.W. Tan, Ulrik Lassen, Serge Leyvraz, Yongmei Liu, Jyoti D. Patel +10 more
Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas
Lin Shen, David S. Hong, Ray McDermott, Vicki L. Keedy, Michela Casanova +19 more
Christine Alewine, Idrees Mian, Anna Spreafico, Lillian L. Siu, Carlos Gomez‐Roca +13 more
Ulrik Lassen, Hans S. Poulsen, Marie-Thérése Stockhausen, Benedikte Hasselbalch
Helene Gellert‐Kristensen, Colm J. O’Rourke, Anne-Sofie Seidelin, Gudmar Thorleifsson, Garðar Sveinbjörnsson +43 more
David S. Hong, Andrew Briggs, Jesús García‐Foncillas, Ulrik Lassen, Gilles Vassal +9 more